Abstract
Psychosis is a particularly distressing psychiatric illness for sufferers and their carers, and it can feel especially difficult for practitioners dealing with its uncertain course and instilling hope in sufferers. Although assessing and managing a patient with psychosis in primary care can be daunting, the majority of patients should also receive input from mental health services. Psychotic symptoms are found in a wide range of medical and psychiatric conditions. Patients with psychosis in later life can be divided into three groups: those with pre-existing schizophrenia, new diagnoses of schizophrenia (‘late-life schizophrenia’, also known as ‘late paraphrenia’) and other conditions producing hallucinations or delusions (dementia, delirium, mood disorders, delusional disorder, paranoid personality disorders). As the population ages and treatments improve, the first group is getting significantly larger and making up a greater proportion of mental illness in older people. The prevalence of all psychotic disorders over 65 years of age is 4–6 %, rising to 10 % over 85 years. However, a large proportion of these cases are related to dementia. True schizophrenia or delusional disorder in the over 65 has a prevalence of 0.5–1.0 %. There is a female preponderance, with a ratio of female to males of 5:1, which is partly because the onset of schizophrenia tends to be later in females. Sixty per cent of older people with psychosis have paranoid schizophrenia, 30 % delusional disorder and only 10 % all other forms of psychosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Geddes P. McKnight psychiatry, 4th ed. Oxford: Oxford University Press; 2012. ISBN 978-0-19-923396-0.
Cowen P, Harrison P. The shorter Oxford textbook of psychiatry, 6th ed. Oxford: Oxford University Press; ISBN 9780199605613.
The World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva: World Health Organization; 1992.
Howard, et al. Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis: an international consensus. Am J Psychiatry. 2000;157:172–8.
Meesters, et al. Schizophrenia spectrum disorders in later life: prevalence and distribution of age at onset and sex in a Dutch catchment area. Am J Geriatr Psychiatry. 2012;20(1):18–28.
Karim S, Byrne E. Treatment of psychosis in elderly people. Adv Psychiatr Treat. 2005;11:286–96.
Palmer, et al. Schizophrenia in late life: findings challenge traditional concepts. Harv Rev Psychiatry. 2001;9:51–8.
Targum SD. Treating psychotic symptoms in elderly patients. Prim Care Companion J Clin Psychiatry. 2001;3:156–63.
Targum SD, Abbott JL. Treating psychotic symptoms in the elderly: a spectrum of disorders. J Clin Psychiatry. 1999;60 Suppl 8:4–10.
National Institute for Health and Care Excellence, Guidelines (CG178), psychosis and schizophrenia in adults: treatment and management, February 2014.
Gaebel W, Weinmann S, Sartorius N. Schizophrenia practice guidelines: international survey and comparison. Br J Psychiatry. 2005;187:248–55.
Taylor et al. The Maudsley, prescribing guidelines in psychiatry, 11th ed. West Sussex, UK: Wiley-Blackwell; 2012. 978-0-470-97948-8.
Douglas, et al. exposure to antipsychotics and risk of stroke: self controlled case series study. Br Med J. 2008;337:a1227.
Munro, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond Pharmacovigilance. Br J Psychiatry. 1999;175:576–80.
O’Connor, et al. The safety and tolerability of Clozapine in aged patients: a retrospective clinical file review. World J Biol Psychiatry. 2010;11:788–91.
Mayersohn M. Special pharmacokinetic considerations in the elderly. In: Evans WE, Schentag JJ, Jusko WJ, editors. Applied pharmacokinetics principles of therapeutic drug monitoring. Spokane: Applied Therapeutics; 1986. p. 229–93.
Morris R, et al. Lithium and eGFR: a new routinely available tool for the prevention of chronic kidney disease. Br J Psychiatry. 2008;193:93–5.
Gurwitz JH. Start low and go slow: dosing of antipsychotic medications in elderly patients with dementia. Arch Intern Med. 1995;155(18):2017–8.
Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–64.
Ucok, Gaebel. Side effects of atypical antipsychotics: a brief overview. World Psychiatry. 2008;7(1):58–62.
Medicines & Healthcare products Regulatory Agency, atypical antipsychotic drugs and stoke, 9th Mar 2004, mhra.gov.uk.
Herman, et al. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry. 2004;161:1113–5.
Lawlor B. Managing behavioural and psychological symptoms in dementia. Br J Psychiatry. 2002;181:463–5.
Lyketsos, et al. Mental and behavioural disturbances in dementia: findings from Cache County Study on Memory and Aging. Am J Psychiatry. 2000;157:708–14.
Margallo-Lana, et al. Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia suffers living in care environments. Int J Geriatr Psychiatry. 2001;16:39–44.
Coen, et al. Behaviour disturbance and other predictors of carer burden in Alzheimer’s disease. Int J Geriatr Psychiatry. 1997;12:331–6.
O’Donnell, et al. Incontinence and troublesome behaviours predict institutionalisation in dementia. J Geriatr Psychiatry Neurol. 1992;5:45–52.
Steele, et al. Psychiatric symptoms and nursing home placement of patients with Alzheimer’s disease. Am J Psychiatry. 1990;147:1049–51.
Finkel SI. Effects of rivastigmine on behavioural and psychological symptoms of dementia in Alzheimer’s disease. Clin Ther. 2004;26:980–90.
Wynn ZJ, Cummings JL. Cholinesterase inhibitor therapies and Neuropsychiatric manifestations of Alzheimer’s disease. Dement Geriatr Cogn Disord. 2004;17:100–1008.
Ballard, et al. A 3 month randomized, placebo-controlled, neuroleptic discontinuation study in 100 people with dementia: the neuropsychiatric inventory median cut off is a predictor of clinical outcome. J Clin Psychiatry. 2004;65:114–9.
Haw, et al. Guidelines on antipsychotics for dementia—are we losing our minds? Psychiatry Bull. 2009;33:57–60.
Wood KA, Harris MJ, Morreale A, Rizos AL. Drug-induced psychosis and depression in the elderly. Psychiatry Clin North Am. 1988;11(1):167–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Karim, S., Harrison, K. (2016). Psychosis in the Elderly. In: Chew-Graham, C., Ray, M. (eds) Mental Health and Older People. Springer, Cham. https://doi.org/10.1007/978-3-319-29492-6_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-29492-6_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29490-2
Online ISBN: 978-3-319-29492-6
eBook Packages: MedicineMedicine (R0)